Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma

31 Aug 2016

Abstract excerpt

// Wen Wang 1, 2, 3, 7 , Lu Zhang 5 , Zheng Wang 2, 3, 7 , Fan Yang 2, 3, 7 , Haoyuan Wang 6, 7 , Tingyu Liang 2, 3, 7 , Fan Wu 3, 4, 7 , Qing Lan 1 , Jiangfei Wang 2, 4, 7 , Jizong Zhao 2, 1, 8 1 Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China 2 Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China 3 Department of...

Source

Identifiers

PMID: 27588397
DOI: 10.18632/oncotarget.11726

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastomaPMID 27588397Read ↗

A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.Semantic proximity Read ↗

A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastomaSemantic proximity Read ↗

MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational StudySemantic proximity Read ↗

Molecular and clinicopathological characterization of a prognostic immune gene signature associated with MGMT methylation in glioblastomaSemantic proximity Read ↗

Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of GlioblastomaSemantic proximity Read ↗

The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma MultiformeSemantic proximity Read ↗

MGMT Promoter Methylation Correlates with an Overall Survival Benefit in Chinese High-Grade Glioblastoma Patients Treated with Radiotherapy and Alkylating Agent-Based Chemotherapy: A Single-Institution StudySemantic proximity Read ↗

Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade GliomasSemantic proximity Read ↗

Integrative Analysis of Dna Methylation and Gene Expression Profiles to Explore Potential Biomarkers of GlioblastomaSemantic proximity Read ↗

Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma PatientsSemantic proximity Read ↗

Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade gliomaSemantic proximity Read ↗

A Novel 16-Genes Signature Scoring System as Prognostic Model to Evaluate Survival Risk in Patients with GlioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.